4
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Preparation of a Relatively Acid-Stable Antigen (CEA) by Disruption of its Specific Precipitate with Antibody

&
Pages 351-365 | Published online: 07 Jul 2009
 

Abstract

The carcinoembryonic antigen (CEA) of intestinal tract cancers is presently purified by extraction from a homogen-ate of such tissues with 1.0M perchloric acid (PCA), followed by two steps of chromatography and one of electrophoresis. In this study, rabbit antisera prepared against such purified CEA, and absorbed with normal human plasma, liver, kidney, spleen and brain, gave a conventional precipitin curve with a water homogenate or with a dialyzed PCA extract of intestinal tract cancers. The immune precipitate was almost completely soluble in PCA. Following dialysis of this solution against cold water, a new precipitate composed mainly of denatured antibody appeared. The remaining solution contained purified antigen. Recovery of this antigen (CEA-R), as judged by radioimmunoassay, appeared optimal when 3.0M PCA was used for disruption of the immune precipitate, and presence of 1.8M urea was helpful. When injected into rabbits, CEA-R was not as strongly antigenic as CEA. Comparison by immunodiffusion and immunoelectrophoresis against their specific rabbit anti-sera indicated that CEA and CEA-R share some specificities but are not identical.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.